Chikungunya

A Phase I Study of PepGNP-ChikV in Healthy Volunteers

Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities

Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale

Trial of an Inactivated Chikungunya Virus Vaccine

Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.

Post-Chikungunya Rheumatism - Rheumatology Follow-up of Patients After 15 Years

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases

Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections

Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia

Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa

Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)

Virological and Immunological Determinants of Arbovirus Infection in New Caledonia

Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu

Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia

A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents

Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia

Cohort of Patients Infected by an Arbovirus

Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.

Baromètre Santé Adulte 2021-2022